ADVENTRX Presents Positive Thiovir Preclinical Results (PR Newswire via Yahoo! Finance)
ADVENTRX Pharmaceuticals, Inc. announced today that data were presented showing strong antiviral synergy without added cytotoxicity with combinations of Thiovir and zidovudine in a series of in vitro tests serving as models for human immunodeficiency virus infection.